|
|
Volumn 51, Issue 10, 2000, Pages 793-803
|
|
Side effects of interferon therapy and their management;Nebenwirkungen der interferontherapie und deren management
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
AMITRIPTYLINE;
BETA INTERFERON;
BETA1A INTERFERON;
CARBIMAZOL HENNING;
CARBIMAZOLE;
DIMENHYDRINATE;
ETILEFRINE;
INTERFERON BETA SERINE;
METOCLOPRAMIDE;
ONDANSETRON;
PARACETAMOL;
POLIDOCANOL;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
THYROXIN HENNING;
THYROXINE;
AUTOIMMUNE DISEASE;
CARDIOTOXICITY;
CHRONIC HEPATITIS;
DRUG INDICATION;
DRUG RESPONSE;
EYE DISEASE;
GASTROINTESTINAL SYMPTOM;
GERMANY;
HUMAN;
HYPERTHYROIDISM;
HYPERTRIGLYCERIDEMIA;
HYPOTHYROIDISM;
IMMUNOTHERAPY;
LIVER TOXICITY;
LUNG TOXICITY;
MENTAL DISEASE;
MULTIPLE SCLEROSIS;
MUSCULOSKELETAL DISEASE;
REVIEW;
SJOEGREN SYNDROME;
SYMPTOMATOLOGY;
VITILIGO;
HUMANS;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
SKIN DISEASES;
SKIN NEOPLASMS;
|
|
EID: 0033787814
PISSN: 00178470
EISSN: None
Source Type: Journal
DOI: 10.1007/s001050051221 Document Type: Review |
|
Times cited : (7)
|
|
References (10)
|
